Preparation of biodegradable microcapsules containing zidovudine (AZT) using solvent evaporation technique

References

• Alex R., Bodmeier R. Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. Journal of Microencapsulation 1990; 7: 347–355
   PubMed Web of Science ®Google Scholar
• Alonso M. J., Cohen S., Park T. G., Gupta R. K., Siber G. R., Langer R. Determinants of release rate of tetanus vaccine from polyester microspheres. Pharmaceutical Research 1993; 10: 945–953
   PubMed Web of Science ®Google Scholar
• Arshady R. Microspheres and microcapsules, a survey of manufacturing techniques: part III: solvent evaporation. Polymer Engineering and Science 1990; 30: 915–924
   Web of Science ®Google Scholar
• Brook I. Approval of zidovudine (AZT) for acquired immunodeficiency syndrome. J. Amer. Med. Ass. 1987; 258: 1517
   PubMed Web of Science ®Google Scholar
• Calverley D., Haley L., Ballem P. Red blood cell alloimmunization in transfused patients on AZT. British Journal of Haematology 1991; 78: 248–250
   PubMed Web of Science ®Google Scholar
• Child S., Montaner J., Tsoukas C., Fanning M., Le T., Wall R. A., Ruedy J. Canadian multicenter azidothymidine trial: AZT pharmacokinetics. Journal of Acquired Immunity Deficiency Syndromes 1991; 4: 865–870
   PubMedGoogle Scholar
• Chow F-P. R., Hamburger A. W. In vivo evaluation of the anemia induced by azidothymidine (AZT) in a murine model of AIDS. European Journal of Haematology 1991; 47: 91–97
   PubMedGoogle Scholar
• Cleland J. L., Langer R. Formulation and delivery of proteins and peptides: design and development strategies. Formulation and Delivery of Proteins and Peptides, J. L. Cleland, R. Langer. American Chemical Society, Washington, DC 1994; 1–19
   Google Scholar
• Colson E. R., Horwitz R. I., Bia F. J., Viscoli C. M. Zidovudine (AZT) for the treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice. Archives of Internal Medicine 1991; 151: 709–713
   PubMedGoogle Scholar
• Devita V. T., Broder S., Fauci A. S., Kovacs J. A., Chabner B. A. Developmental therapeutics and the acquired immunodeficiency syndrome. Annals of Internal Medicine 1987; 106: 568–581
   PubMed Web of Science ®Google Scholar
• Douglas R. D. Antimicrobial agents. The Pharmacological Basis of Therapeutics, A. G. Gilman, T. W. Rall, A. S. Nies, P. Taylor. Pergamon Press, New York 1990; 1182–1184
   Google Scholar
• Drew R. H., Weller S., Gallis H. A., Walmer K. A. R., Bartlett J. A., Blum M. R. Bioequivalence assessment of zidovudine (Retrovir) syrup, solution, and capsule formulations in patients infected with human immunodeficiency virus. Antimicrobial Agents and Chemotherapy 1989; 33: 1801–1803
   PubMed Web of Science ®Google Scholar
• Fischl M. A., Richman D. D., Grieco M. H., Gottlieb M. S., Volverding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Schooley R. T., Jackson G. G., Durack D. T., King D. and the AZT Collaborative Working Group, The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. New England Journal of Medicine 1987; 317: 185–191
   PubMed Web of Science ®Google Scholar
• Fischl M. A., Richman D. D., Hansen N., Collier A. C., Carey J. T., Para M. F., Hardy W. D., Powderly W. G., Allan J. D., Wong B., Merigan T. C., Dolin R., McAuliffe V. J., Hyslop N. E., Rhame F. S., Balfour H. H., Spector S. A., Volberding P., Pettinelli C., Anderson J. and the AIDS Clinical Trials Group, The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. Annals of Internal Medicine 1990; 112: 727–737
   PubMed Web of Science ®Google Scholar
• Fong J. W. US Patent. 4,384,975, 1983, Process for preparation of microspheres
   Google Scholar
• Fong J. W. US Patent. 4,479,911, 1984, Process for preparation of microspheres and modification of release rate of core material
   Google Scholar
• Fong J. W. Microencapsulation by solvent evaporation and organic phase separation process. Controlled Release Systems: Fabrication Technology, D. S. T. Hsieh. CRC Press, Florida 1988; Vol. I: 88–108
   Google Scholar
• Furr B. J., Hutchinson F. G. A biodegradable delivery system for peptides: preclinical experience with the gonadotorphin-releasing hormone agonist Zoladex®. Journal of Controlled Release 1992; 21: 117–128
   Web of Science ®Google Scholar
• Gallo J. M., Sanzgiri Y., Howerth E. W., Finco T. S., Wilson J., Johnston J., Tackett R., Budsberg S. C. Serum, cerebrospinal fluid, and brain concentrations of a new zidovudine formulation following chronic administration via an implantable pump in dogs. Journal of Pharmaceutical Science 1992; 81: 11–15
   PubMedGoogle Scholar
• Gallo J. M., Clark L. N., Rubino J. T. Pump delivery of azidothymidine: potential for constant concentrations and improved brain delivery. Journal of Controlled Release 1989; 9: 249–253
   Google Scholar
• Hirsch M. S. AIDS Commentary. Azidothymidine. Journal of Infectious Disease 1988; 157: 427–431
   PubMedGoogle Scholar
• Kanke M., Simmons G. H., Weiss D. L., Bivins B. A., DeLuca P. P. Clearance of 114Ce-labeled microspheres from blood and distribution in specific organs following intravenous and intraarterial administration in beagle dogs. Journal of Pharmaceutical Science 1980; 69: 755
   PubMed Web of Science ®Google Scholar
• Klecker R., Collins J., Yarchoan R., Thomas R., Jenkins J. F., Broder S., Myers C. E. Plasma and cerebrospinal fluid pharmacokinetics of 3-azido-3-deonythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases. Clinical Pharmacology and Therapeutics 1987; 41: 407–412
   PubMed Web of Science ®Google Scholar
• Lewis D. H. Biodegradable polymers as drug delivery systems. Drugs and Pharmaceutical Sciences, M. Chasin, R. Langer. Marcel Dekker, New York 1990; Vol. 45: 1–42
   Google Scholar
• Lutton J. D., Mathew A., Levere R. D., Abraham N. G. Role of heme metabolism in AZT-induced bone marrow tonicity. American Journal of Haematology 1990; 35: 1–5
   PubMed Web of Science ®Google Scholar
• Nihant N., Stassen S., Grandfils C., Jerome R., Teyssie Ph. Micro-encapsulation by coacervation of poly(lactide-co-glycolide). II Encapsulation of a dispersed aqueous phase. Polymer International 1993; 32: 171–176
   Web of Science ®Google Scholar
• Okada H., Inoue Y., Heya T., Ueno H., Ogawa Y., Toguchi H. Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate. Pharmaceutical Research 1991; 8: 787–791
   PubMed Web of Science ®Google Scholar
• Okada H. One-month release injectable microspheres of leuprolide acetate, a superactive aginist of LH-RH. Proceedings of the International Symposium on Controlled Release of Bioactive Materials 1989; 16: 12–13
   Google Scholar
• Okada H., Ogawa Y., Yashiki T. US Patent. 4,652,441, 1987, Prolonged release microcapsules and its production
   Google Scholar
• Pizzo P. A., Eddy J., Fallon J., Balis F. M., Murphy R. F., Moss H., Wolters P., Brouwers P., Jarosinski P., Rubin M., Broder S., Yarchoan R., Brunetti A., Maha M., Nusinoff-Lehrman S., Poplack D. G. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. New England Journal of Medicine 1988; 319: 889–896
   PubMed Web of Science ®Google Scholar
• Posner M. R., Darnowski W., Calabresi P., Brunetti I., Corvese D., Curt G., Cummings F. J., Clark J., Browne M. J., Beitz J., Weitberg A. B. Oral zidovudine, continuous-infusion fluorouracil, and oral leucovorin calcium: a phase 1 study. Journal of the National Cancer Institute 1990; 82: 1710–1714
   PubMed Web of Science ®Google Scholar
• Richman D. D., Andrews J. Results of continued monitoring of participants in the placebo-controlled trial of zidovudine for serious human immunodeficiency virus infection. American Journal of Medicine 1988; 85: 208–213, (suppl 2A)
   PubMedGoogle Scholar
• Richman D. D., Fischl M. A., Grieco M. H., Gottliab M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Hirsch M. S., Jackson G. G., Durack D. T., Nusinoff-Lehrman S. and the AZT Collaborative Working Group, The tonicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complen. New England Journal of Medicine 1987; 317: 192–197
   PubMed Web of Science ®Google Scholar
• Shargel L., Yu A. B. C. Applied Biopharmaceutics and Pharmacokinetics. Appleton & Lange, Connecticut 1993; 435–463
   Google Scholar
• Schugens Ch., Laruelle N., Nihant N., Grandfils Ch., Jerome R., Teyssie Ph. Effect of emulsion stability on the morphology and porosity of semicrystalline poly 1-lactide microparticles prepared by w/o/w double emulsion-evaporation. Journal of Controlled Release 1994; 32: 161–176
   Web of Science ®Google Scholar
• Van Besauw J. F., Claeys D. A. US Patent. 3,645,911, 1972, Method of encapsulating aqueous or hydrophilic material
   Google Scholar
• Wakiyama N., Juni K., Nakano M. Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics. Chemical and Pharmaceutical Bulletin 1981; 29: 3363
   PubMed Web of Science ®Google Scholar